SE8303050L - Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex - Google Patents

Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex

Info

Publication number
SE8303050L
SE8303050L SE8303050A SE8303050A SE8303050L SE 8303050 L SE8303050 L SE 8303050L SE 8303050 A SE8303050 A SE 8303050A SE 8303050 A SE8303050 A SE 8303050A SE 8303050 L SE8303050 L SE 8303050L
Authority
SE
Sweden
Prior art keywords
enzymet
summents
enzym
pep
humana
Prior art date
Application number
SE8303050A
Other languages
English (en)
Swedish (sv)
Other versions
SE8303050D0 (sv
Inventor
H Ohnishi
H Kozuzume
Y Suzuki
E Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of SE8303050D0 publication Critical patent/SE8303050D0/xx
Publication of SE8303050L publication Critical patent/SE8303050L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8303050A 1982-05-31 1983-05-30 Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex SE8303050L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1982/000213 WO1983004260A1 (en) 1982-05-31 1982-05-31 Human leukocyte pepsin-like enzyme, and a therapeutic agent containing said enzyme as effective ingredient for treating allergic disorder, immune complex disease, and tumor

Publications (2)

Publication Number Publication Date
SE8303050D0 SE8303050D0 (sv) 1983-05-30
SE8303050L true SE8303050L (sv) 1983-12-01

Family

ID=13762278

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303050A SE8303050L (sv) 1982-05-31 1983-05-30 Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex

Country Status (11)

Country Link
US (1) US4591504A ( )
AU (2) AU8459882A ( )
BE (1) BE896895A ( )
CA (1) CA1207262A ( )
DE (1) DE3319360C2 ( )
FR (1) FR2527630B1 ( )
GB (1) GB2125046B ( )
IT (1) IT1172264B ( )
NL (1) NL8301934A ( )
SE (1) SE8303050L ( )
WO (1) WO1983004260A1 ( )

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5995221A (ja) * 1982-11-20 1984-06-01 Mochida Pharmaceut Co Ltd 食細胞機能調節作用を有する医薬組成物
DE3785036D1 (de) * 1987-09-30 1993-04-29 Mucos Emulsionsgesellschaft Mb Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).
ES2038546B1 (es) * 1991-11-08 1994-02-16 Andromaco Lab Procedimiento de obtencion de un producto de naturaleza polipeptidica con actividad inhibidora de la hiperproduccion del factor de necrosis tumoral.
JP2711436B2 (ja) * 1995-02-22 1998-02-10 マルホ株式会社 アレルギー治療剤及びアレルギー対応食品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119872A1 (fr) * 1970-12-30 1972-08-11 Kuban Med I Im Krasnoi Armii Produit a base de pepsine,notamment pour le traitement des maladies s'accompagnant d'une insuffisance secretoire de l'estomac
US3796636A (en) * 1972-07-14 1974-03-12 Wilson Pharm & Chem Corp Process for preparing high activity pepsin
US4229540A (en) * 1979-07-02 1980-10-21 Cutter Laboratories, Inc. Hydrolase purified from human plasma

Also Published As

Publication number Publication date
GB2125046A (en) 1984-02-29
AU8459882A (en) 1983-12-16
IT1172264B (it) 1987-06-18
WO1983004260A1 (en) 1983-12-08
FR2527630B1 (fr) 1986-07-11
SE8303050D0 (sv) 1983-05-30
DE3319360A1 (de) 1983-12-01
CA1207262A (en) 1986-07-08
BE896895A (fr) 1983-09-16
GB2125046B (en) 1985-08-07
AU1507283A (en) 1984-01-19
DE3319360C2 (de) 1986-10-09
GB8314727D0 (en) 1983-07-06
IT8348383A0 (it) 1983-05-27
FR2527630A1 (fr) 1983-12-02
US4591504A (en) 1986-05-27
AU547166B2 (en) 1985-10-10
NL8301934A (nl) 1983-12-16

Similar Documents

Publication Publication Date Title
Šutovská et al. Possible mechanisms of dose-dependent cough suppressive effect of Althaea officinalis rhamnogalacturonan in guinea pigs test system
RU94034104A (ru) Способ увеличения цитотоксичности химиотерапевтического агента, набор для лечения и средство для производства лекарств
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
CN101928743A (zh) 螺旋藻藻蓝蛋白的酶解产物及其应用
SE8303050L (sv) Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex
Vance et al. Endocrine and clinical effects of leuprolide in prostatic cancer
WO2016036273A1 (ru) Лекарственное средство для профилактики и лечения заболеваний дыхательных путей
Newbold Skin markers of malignancy
CA2292902C (en) Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases
Zu et al. Rhizoma Pinelliae trypsin inhibitor separation, purification and inhibitory activity on the proliferation of BGC‑823 gastric adenocarcinoma cells
DERZAVIS et al. TOPICAL BACITRACIN THERAPY OF PYOGENIC DERMATOSES: A Clinical Report
US4056614A (en) Immunity depressant medicine
AU611961B2 (en) Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis
Tung et al. In vivo and in vitro inhibition of human histidine decarboxylase by (S)-α-fluoromethylhistidine
CA1199872A (en) Pharmaceutical methods and compositions
JP2547325B2 (ja) アレルギ−性疾患治療用外用剤
CN108619121A (zh) Fty720在保护神经功能中的用途
TRANQUILLITY of surgical endeavour should benefit many patients. But it is still essential always to bear in mind that early treatment of acute middle-ear infection remains the best method of preventing the chronic condition.
CA1329776C (en) Anti-allergic extract
Knott et al. Penicillin Sprays and Upper Respiratory Tract Infection
Cleveland CONSECUTIVE HERPES ZOSTER AND VARICELLA, WITH VARICELLA IN A CONTACT
CN109134328B (zh) 氨基正己酰甲环酰氨基正己酰Met，其合成，活性和应用
Takahashi et al. Serum angiotensin converting enzyme activity in human bronchial asthma
Middleton Jr et al. Immediate Hypersensitivity: II. Drugs in Clinical Use
Alexandrova et al. Effect of Orally Administered Ammonium Vanadate on the Immune Response of Thmour-Bearing Mice

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8303050-2

Format of ref document f/p: F